Delta Air Lines and Takeda Pharmaceutical enter into SAF agreement

In Georgia, Delta Air Lines and Takeda Pharmaceutical Company Limited have entered into a Sustainable Aviation Fuel (SAF) agreement that will address carbon emissions from the company’s business travel with Delta. Through this agreement, Takeda joins the growing roster of corporate customers entering into SAF agreements facilitated by Delta, representing the shared commitment between both companies to reduce emissions. These partnerships drive investment in the SAF market, building industry demand and broadening the market with the goal of decreasing the aviation industry’s reliance on conventional jet fuel.